Article and Video CATEGORIES
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS). 
In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy.
To start a conversation on this topic, visit https://cancergrace.org/forums/breast-cancer.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…